Sunitinib in combination with mFOLFOX6 chemotherapy in patients with advanced solid tumors: A phase I study

被引：0
|
作者：
Leong, S.
Eckhardt, S.
Chan, E.
Chow, L.
VerMeulen, W.
Camidge, D.
Rothenberg, M.
Chow Maneval, E.
Chao, R.
Lockhart, A.
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Vanderbilt Univ, Med Ctr, Knoxville, TN USA
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII123 / VII123
页数：1
相关论文
共 50 条
  • [31] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Christos E. Kyriakopoulos
    Amy M. Braden
    Jill M. Kolesar
    Jens C. Eickhoff
    Howard H. Bailey
    Jennifer Heideman
    Glenn Liu
    Kari B. Wisinski
    Investigational New Drugs, 2017, 35 : 290 - 297
  • [33] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [34] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [35] Phase I study of sunitinib in combination with carboplatin (C) plus paclitaxel (P) in patients (pts) with advanced solid tumors (STs)
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N. K.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    Schelman, William R.
    Morgan-Meadows, Sherry
    Marnocha, Rebecca
    Lee, Fred
    Eickhoff, Jens
    Huang, Wei
    Pomplun, Marcia
    Jiang, Zhisheng
    Alberti, Dona
    Kolesar, Jill M.
    Ivy, Percy
    Wilding, George
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1147 - 1156
  • [37] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
  • [38] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [39] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Kyriakopoulos, Christos E.
    Braden, Amy M.
    Kolesar, Jill M.
    Eickhoff, Jens C.
    Bailey, Howard H.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari B.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 290 - 297
  • [40] Vandetanib with mFOLFOX6 in advanced colorectal adenocarcinoma: An open-label, multicenter phase I study
    Michael, M.
    Tebbutt, N.
    Gibbs, P.
    Smith, R.
    Godwood, A.
    Oliver, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345